A Comparative Study of Low-Profile and Regular Type Totally Implantable Venous Access Devices in Patients with Malignant Tumors: Retrospective Analysis of 4501 Implantations

被引:0
作者
Akmangit, Ilkay [1 ]
Dede, Dogan [1 ]
Daglioglu, Ergun [2 ]
Sayin, Bige [1 ]
Peker, Ahmet [3 ]
Uncu, Dogan [4 ]
Zengin, Nurullah [4 ]
机构
[1] Ankara Numune Training & Res Hosp, Intervent Radiol Clin, Ankara, Turkey
[2] Ankara Numune Training & Res Hosp, Neurosurg Clin, Ankara, Turkey
[3] Ankara Univ, Fac Med, Dept Radiol, TR-06100 Ankara, Turkey
[4] Ankara Numune Training & Res Hosp, Med Oncol Clin, Ankara, Turkey
来源
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI | 2014年 / 24卷 / 02期
关键词
Port; TIVAD; Low-profile; Regular; Skin perforation; INTERNAL JUGULAR-VEIN; CATHETER-RELATED INFECTIONS; SUPERIOR VENA-CAVA; VASCULAR ACCESS; CANCER-PATIENTS; GUIDED INSERTION; ATRIAL CATHETER; TIP POSITION; PORT DEVICES; HIGH SUCCESS;
D O I
10.4999/uhod.14335
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The purpose of this study was to evaluate safety and efficacy of image-guided radiological totally implantable venous access devices with special reference to rate of skin complications of both regular and low-profile types. 4395 patients were referred to Interventional Radiology Unit between March 2003-September 2013. 4501 implantations of totally implantable venous access device were performed in patients under sonography and fluoroscopy. During this period 2299 regular-type and 2202 low-profile type totally implantable venous access devices were used. Success rate, periprocedural early and long-term complications were evaluated. Periprocedural and early complications of totally implantable venous access devices included 16 (0.4%) arterial punctures, 101(2.2%) minor hematoma, 1 (%0.02) disconnection of the catheter, 4 (0.09%) septum separation, 38(0.8%) minor erythema-pain and tenderness, 23 (0.5%) short term fever without bacteriemia and 25(0.6%) inversion of the port. Late complications included 6(0.1%) cellulitis, 8(0.2%) bacteriemia and sepsis, 305 (6.8%) venous thrombosis, 62 (1.4%) catheter thrombosis, 6 (0.1%) catheter migration and 3 (0.07%) catheter fracture. A total of 53 (1.18%) skin perforation were seen. There was statistically significant difference between regular and low-profile totally implantable venous access devices particularly in patients with normal and thinner subcutaneous fat tissue (p= 0.024 and <0.001 respectively). The present study is the largest series in the literature in patients with malignant tumors. Image-guided radiological totally implantable venous access device placement is safe and reliable method with a low risk of complications and the results of this study further justify the use of low profile totally implantable venous access device based on lower skin complications.
引用
收藏
页码:97 / 105
页数:9
相关论文
共 71 条
[1]  
A-Rahman A, 2003, COCHRANE DB SYST REV, V5
[2]   Subclavian Vein Versus Arm Vein for Totally Implantable Central Venous Port for Patients with Head and Neck Cancer: A Retrospective Comparative Analysis [J].
Akahane, Akio ;
Sone, Miyuki ;
Ehara, Shigeru ;
Kato, Kenichi ;
Tanaka, Ryoichi ;
Nakasato, Tatsuhiko .
CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, 2011, 34 (06) :1222-1229
[3]   A comparative study between two central veins for the introduction of totally implantable venous access devices in 1201 cancer patients [J].
Araujo, C. ;
Silva, J. P. ;
Antunes, P. ;
Fernandes, J. M. ;
Dias, C. ;
Pereira, H. ;
Dias, T. ;
Fougo, J. L. .
EJSO, 2008, 34 (02) :222-226
[4]   CENTRAL VENOUS CATHETER-RELATED THROMBOSIS IN CLINICALLY ASYMPTOMATIC ONCOLOGIC PATIENTS - A PHLEBOGRAPHIC STUDY [J].
BALESTRERI, L ;
DECICCO, M ;
MATOVIC, M ;
CORAN, F ;
MORASSUT, S .
EUROPEAN JOURNAL OF RADIOLOGY, 1995, 20 (02) :108-111
[5]  
Barwinska-Poblocka K, 2013, GINEKOL POL, V84, P339
[6]   Risk of thrombosis and infections of central venous catheters and totally implanted access ports in patients treated for cancer [J].
Beckers, M. M. J. ;
Ruven, H. J. T. ;
Seldenrijk, C. A. ;
Prins, M. H. ;
Biesma, D. H. .
THROMBOSIS RESEARCH, 2010, 125 (04) :318-321
[7]  
Benter T, 2001, ULTRASCHALL MED, V22, P23
[8]   Use of totally implantable central venous access ports for high-dose chemotherapy and peripheral blood stem cell transplantation: results of a monocentre series of 376 patients [J].
Biffi, R ;
Pozzi, S ;
Agazzi, A ;
Pace, U ;
Floridi, A ;
Cenciarelli, S ;
Peveri, V ;
Cocqui, A ;
Andreoni, B ;
Martinelli, G .
ANNALS OF ONCOLOGY, 2004, 15 (02) :296-300
[9]   Best choice of central venous insertion site for the prevention of catheter-related complications in adult patients who need cancer therapy: a randomized trial [J].
Biffi, R. ;
Orsi, F. ;
Pozzi, S. ;
Pace, U. ;
Bonomo, G. ;
Monfardini, L. ;
Della Vigna, P. ;
Rotmensz, N. ;
Radice, D. ;
Zampino, M. G. ;
Fazio, N. ;
de Braud, F. ;
Andreoni, B. ;
Goldhirsch, A. .
ANNALS OF ONCOLOGY, 2009, 20 (05) :935-940
[10]   Totally implantable central venous access ports for long-term chemotherapy - A prospective study analyzing complications and costs of 333 devices with a minimum follow-up of 180 days [J].
Biffi, R ;
de Braud, E ;
Orsi, E ;
Pozzi, S ;
Mauri, S ;
Goldhirsch, A ;
Nole, F ;
Andreoni, B .
ANNALS OF ONCOLOGY, 1998, 9 (07) :767-773